LDLR and atherosclerosis: Zhu et al. [26] demonstrated that immunized diabetic ApoE−/− and low-density lipoprotein (LDL) receptor knockout (LDLR)−/− mice with AGE-LDL significantly reduced atherosclerosis, indicating that vaccination with AGE-LDL may offer a novel approach for the treatment of atherosclerosis in patients with diabetes.